Stockscreener 앱 받기
87.43
2.62%
2.23
시간 외 거래:
87.43
전일 마감가:
$85.20
열려 있는:
$85.93
하루 거래량:
1.06M
Relative Volume:
0.89
시가총액:
$9.74B
수익:
$13.38B
순이익/손실:
$418.00M
주가수익비율:
26.40
EPS:
3.3112
순현금흐름:
$391.00M
1주 성능:
-0.10%
1개월 성능:
-1.21%
6개월 성능:
+20.94%
1년 성능:
+28.72%
1일 변동 폭
$85.58
$87.64
1주일 범위
$84.15
$88.32
52주 변동 폭
$61.95
$92.18
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
87.43 | 9.85B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
891.23 | 102.78B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
314.43 | 61.36B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
222.04 | 54.56B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
0.7401 | 718.95M | 14.85M | -136.07M | 7.25M | -0.4726 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-16 | 개시 | BTIG Research | Neutral |
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Henry Schein Inc Share PriceHSIC, RNS News, Articles, Quotes, & Charts (NASDAQ:HSIC) - Proactive financial news
Henry Schein stock holds firm after a fresh target lift - ad-hoc-news.de
Henry Schein stock heads into the open after a 1.0% daily loss - ad-hoc-news.de
Henry Schein Executive Andrea Albertini Reports Two Stock Disposals on September 8, 2026 - Kalkine Media
Tax withholding prompts Henry Schein (HSIC) insider to return shares - Stock Titan
Henry Schein stock holds steady after recent earnings update - ad-hoc-news.de
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Precision Trading with Henry Schein Inc. (HSIC) Risk Zones - Stock Traders Daily
Henry Schein stock rises on a new distribution deal - ad-hoc-news.de
Henry Schein to Present at Baird Global Healthcare Conference - dentistrytoday.com
Henry Schein to Distribute Applied BioCode's MDx-3000 System in US - marketscreener.com
Applied BioCode Announces Distribution Agreement with Henry Schein - Business Wire
Henry Schein to Participate in Upcoming Investor Conference in September - Business Wire
How Investors May Respond To Henry Schein (HSIC) Distributing DermaSensor’s Skin Cancer Detection Device - webull.com
Henry Schein stock gains after strong Q2 2026 results and raised outlook - ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.33% Upside Opportunity in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein stock gains institutional support as new diagnostic partnership advances strategy - AD HOC NEWS
Henry Schein Inc. helps children start the school year - Reading Eagle
Henry Schein stock rises after Q2 earnings beat - AD HOC NEWS
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report? - Yahoo Finance
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein shares technical analysis: Resistance test at $92.68 in focus - Traders Union
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Eastern Progress
Is Henry Schein (HSIC) Stock Undervalued Right Now? - Yahoo Finance
Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available? - Yahoo Finance
Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.68% Upside Potential in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein, Inc. (HSIC) Stock Report: Analyst Consensus Points to 10.95% Potential Upside - DirectorsTalk Interviews
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - fortune.com
Henry Schein stock holds steady as 2026 outlook is raised and Q2 earnings beat - Ad-hoc-news.de
What Are Wall Street Analysts' Target Price for Henry Schein Stock? - Yahoo Finance
Is HSIC Worth Buying as Growth Improves but Execution Risks Persist? - TradingView
Henry Schein, Special Olympics re-up partnership - HME News
Henry Schein (NASDAQ:HSIC) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018. - marketscreener.com
BTIG Adjusts Price Target on Henry Schein to $110 From $100, Maintains Buy Rating - marketscreener.com
Henry Schein and Special Olympics Renew Partnership Through 2030 - Orthodontic Products
Henry Schein stock holds steady as higher-margin Q2 2026 lifts guidance - AD HOC NEWS
Building a healthier future together: Henry Schein and Special Olympics renew partnership through 2030 - Special Olympics
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates - TradingView
Empowered Funds LLC Has $851,000 Position in Henry Schein, Inc. $HSIC - MarketBeat
Buckland Partners Management Co LLC Makes New Investment in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein stock holds near a 52-week high after a Buy upgrade - Ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Growth Potential Amidst a 8.68% Upside - DirectorsTalk Interviews
Henry Schein (NASDAQ:HSIC) Rating Increased to Buy at Wall Street Zen - MarketBeat
How Henry Schein’s Strong Q2 Earnings and Higher 2026 Sales Outlook Will Impact Henry Schein (HSIC) Investors - simplywall.st
Form 144 | Henry Schein(HSIC.US) Insider Proposes to Sell 3.18 Million in Common Stocks - Moomoo
Henry Schein (HSIC) insider Bergman plans $3.18M sale under Form 144 - Stock Titan
HSIC|Henry Schein Inc|Price:90.000|Chg%:+0.230 - tradingkey.com
5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call - Yahoo Finance
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.62%
0.71%
자본화:
|
볼륨(24시간):